First Time Loading...

Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 24.66 USD -2.76% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

1.1B
-0.2%
Assets
Growth Rates:
1 Year
-4%
3 Years
-19%
5 Years
-26%
7 Years
-10%
10 Years
+52%
363.3m
-22%
Liabilities
Growth Rates:
1 Year
+16%
3 Years
-32%
5 Years
-26%
7 Years
-33%
10 Years
+350%
783.2m
+15%
Equity
Growth Rates:
1 Year
-12%
3 Years
-11%
5 Years
-26%
7 Years
+7%
10 Years
+16%

Balance Sheet Decomposition
Myriad Genetics Inc

1.1B
Assets
363.3m
Liabilities
1.1B
Assets
363.3m
Liabilities
Current Assets 313.6m
Cash & Short-Term Investments 140.9m
Receivables 114.3m
Other Current Assets 58.4m
Non-Current Assets 832.9m
PP&E 180.6m
Intangibles 636.9m
Other Non-Current Assets 15.4m
Current Liabilities 155.9m
Accounts Payable 25.8m
Accrued Liabilities 104.8m
Other Current Liabilities 25.3m
Non-Current Liabilities 207.4m
Long-Term Debt 38.5m
Other Non-Current Liabilities 168.9m

Balance Sheet
Myriad Genetics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
117
258
57
132
Cash
0
0
54
130
Cash Equivalents
117
258
3
2
Short-Term Investments
34
81
58
9
Total Receivables
92
91
102
114
Accounts Receivables
90
91
102
114
Other Receivables
2
0
0
0
Inventory
27
15
20
22
Other Current Assets
120
38
38
36
Total Current Assets
389
485
275
314
PP&E Net
100
125
187
181
PP&E Gross
100
125
187
181
Accumulated Depreciation
113
107
109
120
Intangible Assets
577
404
380
350
Goodwill
329
239
287
287
Long-Term Investments
21
59
55
0
Other Long-Term Assets
2
8
16
15
Other Assets
329
239
287
287
Total Assets
1 419
N/A
1 321
-7%
1 199
-9%
1 147
-4%
Liabilities
Accounts Payable
21
30
29
26
Accrued Liabilities
70
146
79
105
Short-Term Debt
0
0
0
0
Other Current Liabilities
55
29
29
25
Total Current Liabilities
146
204
137
156
Long-Term Debt
225
0
0
39
Deferred Income Tax
71
36
4
0
Minority Interest
0
0
0
0
Other Liabilities
96
113
172
169
Total Liabilities
538
N/A
353
-34%
313
-11%
363
+16%
Equity
Common Stock
1
1
1
1
Retained Earnings
227
254
366
630
Additional Paid In Capital
1 110
1 226
1 260
1 416
Other Equity
2
5
9
4
Total Equity
881
N/A
968
+10%
886
-8%
783
-12%
Total Liabilities & Equity
1 419
N/A
1 321
-7%
1 199
-9%
1 147
-4%
Shares Outstanding
Common Shares Outstanding
75
80
81
90

See Also

Summary
MYGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
MYGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MYGN stock valuation using valuation multiples.
Wall Street Estimates
MYGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MYGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.